Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients

B Austen, Giancarlo Barone, Anne Reiman, Philip Byrd, C Baker, J Starczynski, MC Nobbs, RP Murphy, H Enright, E Chaila, J Quinn, Tatjana Stankovic, Guy Pratt, Alexander Taylor

Research output: Contribution to journalArticle

15 Citations (Scopus)


Ataxia Telangiectasia (A-T) patients have biallelic inactivation of the ATM gene and exhibit a 200-fold-increased frequency of lymphoid tumours. ATM mutations have been found in a number of adult lymphoid malignancies but there is no data on the occurrence of ATM mutations in multiple myeloma tumours. The purpose of our work was to investigate the occurrence of ATM mutations in multiple myeloma and to this end we screened 45 sporadic cases for ATM mutations using denaturing high-performance liquid chromatography analysis and DNA sequencing. Pathogenic ATM mutations were identified in 2/45 of the myelomas compared with a published estimate of ATM mutant allele frequency in the UK population of 2/521 (P = 0.033). One was the missense mutation 7181C>T which was then modelled in an expression system and the S2394L protein shown to have no ATM kinase activity. The second myeloma had the pathogenic ATM splice site mutation IVS40-1G>C leading to loss of exon 41. We also report a 48-year-old ataxia telangiectasia patient who developed multiple myeloma. Taken together our study suggests that ATM mutation may play a role in the pathogenesis of a subset of multiple myelomas.
Original languageEnglish
Pages (from-to)925-933
Number of pages9
JournalBritish Journal of Haematology
Issue number6
Publication statusPublished - 1 Sept 2008


  • multiple myeloma
  • ataxia telangiectasia


Dive into the research topics of 'Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients'. Together they form a unique fingerprint.

Cite this